Home > Insider Trading > Filing (0001209191-18-026607)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197032	F Ian Smith	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-04-25	4,250	$77.31	68,745	No	4	M	Direct
Common Stock	Acquisiton	2018-04-25	2,156	$91.05	70,901	No	4	M	Direct
Common Stock	Acquisiton	2018-04-25	7,766	$86.52	78,667	No	4	M	Direct
Common Stock	Disposition	2018-04-25	19,478	$154.98	59,189	No	4	S	Direct
Common Stock	Disposition	2018-04-25	9,790	$155.62	49,399	No	4	S	Direct
Common Stock	Disposition	2018-04-25	2,700	$156.78	46,699	No	4	S	Direct
Common Stock	Acquisiton	2018-04-26	2,125	$96.87	48,824	No	4	M	Direct
Common Stock	Acquisiton	2018-04-26	51,000	$109.14	99,824	No	4	M	Direct
Common Stock	Disposition	2018-04-26	53,125	$160.12	46,699	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy	Disposition	2018-04-25	4,250	$0.00	4,250	$77.31
Common Stock	Stock Option (Right to Buy	Disposition	2018-04-25	2,156	$0.00	2,156	$91.05
Common Stock	Stock Option (Right to Buy	Disposition	2018-04-25	7,766	$0.00	7,766	$86.52
Common Stock	Stock Option (Right to Buy	Disposition	2018-04-26	2,125	$0.00	2,125	$96.87
Common Stock	Stock Option (Right to Buy	Disposition	2018-04-26	51,000	$0.00	51,000	$109.14

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2024-02-04	No	4	M	Direct
17,241	2026-02-01	No	4	M	Direct
23,299	2027-02-02	No	4	M	Direct
2,125	2024-07-14	No	4	M	Direct
17,000	2025-02-02	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,306	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $154.98 (range $154.32 to $155.31).
Open market sales reported on this line occurred at a weighted average price of $155.62 (range $155.32 to $156.29).
Open market sales reported on this line occurred at a weighted average price of $156.78 (range $156.38 to $157.29).
Open market sales reported on this line occurred at a weighted average price of $160.12 (range $160.00 to $160.23).
Fully vested.
The option vests in 16 quarterly installments from 02/02/2016.
The option vests in 16 quarterly installments from 02/03/2017.
The option vests in 16 quarterly installments from 07/15/2014.
The option vests in 16 quarterly installments from 02/03/2015.